Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
C-Bond Systems, Inc., a nanotechnology enterprise founded in 2013 and based in Houston, Texas, concentrates on the ownership, development, production, and sale of its proprietary C-Bond technology across the United States. The company's innovative product line, rooted in C-Bond technology, includes: C-Bond NanoShield: A patented nanotechnology system designed to bolster windshield safety and performance through glass strengthening and the application of hydrophobic properties. C-Bond Secure: This patented, non-toxic, water-based nanotechnology solution enhances the durability of architectural glass and improves the functional characteristics of window film-to-glass integrations. C-Bond BRS: A patented nanotechnology ballistic-resistant film system that substantially increases the structural integrity of glass. Beyond its core C-Bond offerings, the company also distributes MB-10 and Vimoba disinfectant tablets. These products are supplied to a broad spectrum of clients and markets, encompassing educational institutions (schools and buses), automotive dealerships, global distribution networks, a variety of service providers, and sectors such as transportation detailing, automotive, trucking, RVs, rental agencies, service vehicles, mass transit, golf carts, aviation, trains, and marine operations.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD